Envestnet Portfolio Solutions’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
3,970
-295
-7% -$77.5K 0.01% 664
2026
Q1
$1.14M Sell
4,265
-1,612
-27% -$436K 0.01% 594
2025
Q4
$1.47M Sell
5,877
-385
-6% -$102K 0.01% 638
2025
Q3
$1.8M Sell
6,262
-561
-8% -$150K 0.01% 554
2025
Q2
$1.79M Sell
6,823
-75
-1% -$18.3K 0.01% 594
2025
Q1
$1.61M Sell
6,898
-3,171
-31% -$770K 0.01% 655
2024
Q4
$2.31M Buy
10,069
+525
+6% +$120K 0.01% 620
2024
Q3
$2.13M Buy
9,544
+589
+7% +$129K 0.01% 640
2024
Q2
$1.82M Buy
8,955
+1,038
+13% +$211K 0.01% 662
2024
Q1
$1.73M Sell
7,917
-2,215
-22% -$488K 0.01% 682
2023
Q4
$2.3M Sell
10,132
-430
-4% -$90.3K 0.01% 554
2023
Q3
$2.12M Buy
+10,562
New +$2.23M 0.01% 530

Other funds holding LH

Envestnet Portfolio Solutions's LH Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Labcorp (LH) stake by 6.9% in Q2 2026, selling an estimated $77.5K and leaving 3,970 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #664.

Envestnet Portfolio Solutions first reported a position in LH in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.31M in Q4 2024. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Envestnet Portfolio Solutions held 3,970 shares of Labcorp worth $1.11M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 295 Labcorp shares in Q2 2026, an estimated $77.5K.
  • Labcorp made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #664 holding.
  • Envestnet Portfolio Solutions first reported a position in Labcorp in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Labcorp position peaked at $2.31M in Q4 2024.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.